Gelmon KA - Search Results

1

Randomized phase II study of BR96-doxorubicin conjugate in patients with metastatic breast cancer.

Tolcher AW, Sugarman S, Gelmon KA, Cohen R, Saleh M, Isaacs C, Young L, Healey D, Onetto N, Slichenmyer W. Tolcher AW, et al. Among authors: gelmon ka. J Clin Oncol. 1999 Feb;17(2):478-84. doi: 10.1200/JCO.1999.17.2.478. J Clin Oncol. 1999. PMID: 10080588 Clinical Trial.

2

Efficacy of weekly cisplatin-based chemotherapy in recurrent and metastatic head and neck cancer.

Osoba D, Band PR, Goldie JH, Connors JM, Gelmon K, Knowling MA, Fetherstonhaugh EM. Osoba D, et al. Ann Oncol. 1992 Aug;3 Suppl 3:57-62. doi: 10.1093/annonc/3.suppl_3.s57. Ann Oncol. 1992. PMID: 1390318

3

Biweekly paclitaxel in the treatment of patients with metastatic breast cancer.

Gelmon KA. Gelmon KA. Semin Oncol. 1995 Oct;22(5 Suppl 12):117-22. Semin Oncol. 1995. PMID: 7481853 Clinical Trial.

4

Biweekly paclitaxel and cisplatin: a phase I/II study in the first-line treatment of metastatic breast cancer.

O'Reilly SE, Gelmon KA. O'Reilly SE, et al. Among authors: gelmon ka. Semin Oncol. 1995 Jun;22(3 Suppl 6):109-11. Semin Oncol. 1995. PMID: 7597426 Clinical Trial.

5

Interim results of a phase I/II study of biweekly paclitaxel and cisplatin in patients with metastatic breast cancer.

Tolcher AW, Gelmon KA. Tolcher AW, et al. Among authors: gelmon ka. Semin Oncol. 1995 Aug;22(4 Suppl 8):28-32. Semin Oncol. 1995. PMID: 7638639 Clinical Trial.

6

Biweekly paclitaxel (Taxol) and cisplatin in breast and ovarian cancer.

Gelmon KA. Gelmon KA. Semin Oncol. 1994 Oct;21(5 Suppl 8):24-8. Semin Oncol. 1994. PMID: 7939758 Clinical Trial.

7

Adjuvant systemic therapy and survival after breast cancer.

Olivotto IA, Bajdik CD, Plenderleith IH, Coppin CM, Gelmon KA, Jackson SM, Ragaz J, Wilson KS, Worth A. Olivotto IA, et al. Among authors: gelmon ka. N Engl J Med. 1994 Mar 24;330(12):805-10. doi: 10.1056/NEJM199403243301201. N Engl J Med. 1994. PMID: 8114832 Free article.

8

Phase I trial of recombinant human granulocyte-macrophage colony-stimulating factor derived from yeast in patients with breast cancer receiving cyclophosphamide, doxorubicin, and fluorouracil.

O'Reilly SE, Gelmon KA, Onetto N, Parente J, Rubinger M, Page RA, Plenderleith IH. O'Reilly SE, et al. Among authors: gelmon ka. J Clin Oncol. 1993 Dec;11(12):2411-6. doi: 10.1200/JCO.1993.11.12.2411. J Clin Oncol. 1993. PMID: 8246030 Clinical Trial.

9

Phase I/II trial of biweekly paclitaxel and cisplatin in the treatment of metastatic breast cancer.

Gelmon KA, O'Reilly SE, Tolcher AW, Campbell C, Bryce C, Ragaz J, Coppin C, Plenderleith IH, Ayers D, McDermott B, Nakashima L, Healey D, Onetto N. Gelmon KA, et al. J Clin Oncol. 1996 Apr;14(4):1185-91. doi: 10.1200/JCO.1996.14.4.1185. J Clin Oncol. 1996. PMID: 8648373 Clinical Trial.

10

Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer.

Nabholtz JM, Gelmon K, Bontenbal M, Spielmann M, Catimel G, Conte P, Klaassen U, Namer M, Bonneterre J, Fumoleau P, Winograd B. Nabholtz JM, et al. J Clin Oncol. 1996 Jun;14(6):1858-67. doi: 10.1200/JCO.1996.14.6.1858. J Clin Oncol. 1996. PMID: 8656254 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

240 results

Search Page

Filters